Treatment Project To New U.S. Entity

Hofseth Biocare ASA

15/05/2023 10:01

May 15 (Reuters) - Hofseth Biocare ASA  HBC.OL :
    * REG-HOFSETH BIOCARE ASA: SPIN-OFF OF PROSTATE CANCER
CO-TREATMENT PROJECT
    * DECISION TO TRANSFER ITS PROSTATE CANCER CO-TREATMENT
PROJECT (
"PROJECT") TO A NEW US ENTITY TO BE CALLED HBC IMMUNOLOGY INC.
    * HBCI WILL DEVELOP A CO-THERAPEUTIC TREATMENT FOR PROSTATE
CANCER
AS WELL AS OTHER POTENTIAL INDICATIONS RELATED TO ABNORMAL
CELLULAR IRON REGULATION

Source text for Eikon:  ID:nGNEby8Z07 
Further company coverage:  HBC.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))